Provided by Tiger Trade Technology Pte. Ltd.

Pfizer

28.37
-0.0300-0.11%
Post-market: 28.380.0100+0.04%17:35 EDT
Volume:26.82M
Turnover:760.22M
Market Cap:161.30B
PE:37.34
High:28.61
Open:28.61
Low:28.13
Close:28.40
52wk High:29.21
52wk Low:23.62
Shares:5.69B
Float Shares:5.64B
Volume Ratio:0.95
T/O Rate:0.48%
Dividend:1.72
Dividend Rate:6.07%
EPS(TTM):0.7599
EPS(LYR):1.36
ROE:5.01%
ROA:5.78%
PB:1.89
PE(LYR):20.79

Loading ...

Enodia Therapeutics: Pfizer Will be Responsible for All Clinical, Manufacturing, Regulatory and Commercial Activities

THOMSON REUTERS
·
Yesterday

Enodia Therapeutics Announces Research Collaboration and License Agreement with Pfizer to Develop SEC61-Targeting Small Molecules

THOMSON REUTERS
·
Yesterday

Enodia Therapeutics : Deal with Pfizer Has Total Potential Value over $500M Including Upfront, Milestones and Royalties

THOMSON REUTERS
·
Yesterday

Analysts Conflicted on These Healthcare Names: 4D Molecular Therapeutics (FDMT), Pfizer (PFE) and Incyte (INCY)

TIPRANKS
·
Yesterday

Analysts Offer Insights on Healthcare Companies: Cogstate Ltd (OtherCOGZF) and Pfizer (PFE)

TIPRANKS
·
Yesterday

Reddit and Perplexity AI Clash over Law Firm's Role in Data-Scraping Case

Reuters
·
Yesterday

Analysts Offer Insights on Healthcare Companies: Pfizer (PFE), ACADIA Pharmaceuticals (ACAD) and Insmed (INSM)

TIPRANKS
·
Yesterday

High-Yield Stocks Are Back, But Beware The Value Traps

Options & Short Sell
·
Oct 12

The $3.8 Billion AI Startup With Zero Drugs — Why Big Pharma Keeps Signing the Checks

AI Industry Frontlines
·
Oct 11

5%, Really? the Stock Market's Sudden High-Yielders.

Dow Jones
·
Oct 11

Pfizer (PFE) Ramps Up Three Phase 3 Trials, Tempting Bulls

TIPRANKS
·
Oct 10

The S&P 500's Hidden Divide: Why 117 Stocks Now Pay You More Than 3% To Wait

Sector Pulse
·
Oct 10

Pfizer Inc. Stock Underperforms Friday When Compared to Competitors Despite Daily Gains

Dow Jones
·
Oct 10

Pfizer’s New RSV Vaccine Trial Targets Older Adults, Signaling Long-Term Growth Potential

TIPRANKS
·
Oct 10

Pfizer’s New Asthma Bet: Tilrekimig Phase 3 Trial Moves Forward

TIPRANKS
·
Oct 10

5%, Really? the Stock Market's Sudden High-Yielders.

Dow Jones
·
Oct 09

BofA Securities Adjusts Pfizer Price Target to $29 From $27, Maintains Neutral Rating

MT Newswires Live
·
Oct 09

J.P. Morgan Keeps Their Hold Rating on Pfizer (PFE)

TIPRANKS
·
Oct 09

An AI Transformation That Finally Let Pfizer CEO Albert Bourla Sleep Soundly

Deep News
·
Oct 09

Pfizer Limited Confirms SEBI Compliance on Share Dematerialization for Q3 2026

TIPRANKS
·
Oct 09